Navigation Links
VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
Date:11/26/2007

BASKING RIDGE, N.J., Nov. 26 /PRNewswire-FirstCall/ -- VioQuest Pharmaceuticals (OTC Bulletin Board: VQPH) today announced the initiation of a Phase IIa study of Lenocta(TM) (sodium stibogluconate), a novel protein tyrosine phosphatase inhibitor, in combination with interferon alpha, an immune stimulant approved for the treatment of hepatitis C, hepatitis B and a number of cancers. The open-label Phase IIa study is designed to enroll at least 12 more patients.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070117/NYW085LOGO )

The Phase IIa trial will evaluate the clinical efficacy and biological effectiveness of Lenocta at the highest tolerable dose in combination with interferon alpha in patients with advanced-stage solid tumors.

"We have reached a significant milestone in the development of Lenocta as a potential cancer therapy with the initiation of this trial," said Michael D. Becker, President and Chief Executive Officer of VioQuest Pharmaceuticals. "We will continue to advance our portfolio of novel compounds for various cancer indications into clinical development, the goal of this drug development organization."

Razelle Kurzrock M.D., Professor of Medicine Chair, Department of Investigational Cancer Therapeutics at The University of Texas M.D. Anderson Cancer Center is the lead principal investigator for the study, while Aung Naing M.D. of the same institution and Claire Verschraegen M.D. of The University of New Mexico Cancer Center are participating co-principal investigators.

Data from the recently concluded Phase I trial for Lenocta demonstrated pharmacodynamic activity in some solid tumors as demonstrated by increases in the activities of natural killer cells, CD8 and type II dendritic cells.

About Lenocta

Lenocta, a pentavalent antimonial originally used for the treatment of the parasitic disease leishmaniasis, is an
'/>"/>

SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...RNIE, Md., Dec. 1 Sleep Solutions&...provider for home testing and evaluation of sleep-... Richard Hassett, M.D., as its chief executive off...ia Healthcare, during its growth from a $250 milli...industry leader in total population health, and it...
(Date:12/1/2009)...RQUE, N.M., Dec. 1 Exagen Diagnost... discovers, develops and markets proprietary genom... Glenn as chairman of the company,s board of direc...oining Exagen, Glenn was managing partner of Winda...uccessful biomedical companies including Prometheu...
(Date:12/1/2009)... BEIJING, Dec. 1 /PRNewswire-Asia/ -- Sinovac B...biopharmaceutical products in China, announced tod...for its H1N1 vaccine, PANFLU.1(TM),from China,s M... the national,purchase plan. Under this purchase o... one million doses of PANFLU.1 (TM) (15ug/0.5ml) f...
Breaking Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Swine Flu Virus Not Mutating Making Vaccine a Good Match 58364 1Swine Flu Virus Not Mutating Making Vaccine a Good Match 58364 2Swine Flu Virus Not Mutating Making Vaccine a Good Match 58364 3Pitt researchers net 245 million from NIH to explore better ways to grow cells 10117 1Pitt researchers net 245 million from NIH to explore better ways to grow cells 10117 2Pitt researchers net 245 million from NIH to explore better ways to grow cells 10117 3NSF funds states first imaging system for UAB microscale research lab 10112 1NSF funds states first imaging system for UAB microscale research lab 10112 2
...ne 17 ,Oridion Systems Ltd. - (SWX: ORIDN) Signifi...cts demonstrating the clinical benefit of end-tida...ography technology, were,recently presented at med... During Digestive Disease Week (DDW) in San Diego,...resented a blinded study that analyzed 122,randomi...
...ns of Novel Targeted Agents Under the Comp... Anti-Viral Potential of These New Agents Supporte...tion of Immunologists Annual Meeting -, TUSTIN, C...asdaq: PPHM ), a clinical stage biopharmaceutical...treatment of cancer and,hepatitis C virus infectio...
Other Medicine Technology:Oridion Announces Major Medical Research and Congress Presentations 2Oridion Announces Major Medical Research and Congress Presentations 3Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 4
(Date:12/1/2009)...rages Older Persons and Healthcare Workers to Get ...Authority Data ,, HARRISBURG, Pa., Dec. 1 /PR...ine preventable deaths occur in those 65 and older...to highlighted studies in the Pennsylvania Patient...Advisory . ,, According to the Centers for Dise...
(Date:12/1/2009)...s with age are more likely to engage in risky heal...ed negative view of the aging process may act as a...hem to make the most of the present in anticipatio.... John Garry and Dr. Maria Lohan from Queen,s Univ...line in Springer,s Journal of Happiness Studies ....
(Date:12/1/2009)...c achievement, study finds , , TUESDAY, ...system in young adulthood may boost brainpower, ma...cess later in life, new research suggests. , Gi...d know) the benefits of exercise and its impact on...ring in this week,s online issue of the Proceedin...
(Date:12/1/2009)... 1 The first nutrition bar contain...d for its potential to forestall the ravages of ti... http://www.newscom.com/cgi-bin/prnh/20091201/NY1...in/prnh/20091111/NY08935LOGO ) ,, The aptly-na... Rancho Santa Fe, Calif. contains as much resverat...
(Date:12/1/2009)...ire/ -- , - At ECPA,s Food Supply Forum, ...des of Agriculture Will Require Science-Based Solu...ntific Adviser to the UK government,asserted that...e and have a,sound evidence basis. "Having a chief...k at all stages of policy development has real pot...
Breaking Medicine News(10 mins):Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Binge drinking youths find getting old a drag 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3Health News:First Resveratrol Nutrition Bar Hits the Market 2Health News:Food Security to be the Top Issue for EU's Science Chief 2
...a: Two Indonesian women have died from avian flu, ...se to 61, officials said Saturday. // Yulfa, ...arta resident Ani Apriani, 22, died early Saturday...id an official at the Indonesian health ministry. ...
...ine’s Day often brings hopes of romance, sometimes...tance from products marketed as human pheromones. ...George Preti, PhD and Charles Wysocki, PhD, scient...ow, human pheromones do not act as sex attractants...
...s in Toronto have been alerted to be watchful for ... has been sounded after recent reports, of increas...cent report has established the increase in cases ...t the illness and improved detection procedures ha...
...lhi: Science and Technology Minister Kapil Sibal F...gue and Hepatitis-C diseases in just an hour.// ...e for Genetic Engineering and Biotechnology (ICGEB...ly readable signal that makes it easy for early di...
...en with learning disabilities are vulnerable to se...ills so that they can protect themselves.// ...udent with disabilities by her special needs teach... When it comes to allegations of rape and sex...
...bout every adult these days knows that a diet lade...regular exercise and risky behaviors like smoking ...s and heart attacks. But a renowned heart disease ...news: The fix is free. That’s because it costs not...
Other Medicine News:Health News:Human Pheromones: Fact and Fiction 2Health News:Special Children Need to Be Taught Sexual Safety 2Health News:Special Children Need to Be Taught Sexual Safety 3Health News:Cure for Most Heart Attacks Is Free, but It's Important to Start Young 2Health News:Cure for Most Heart Attacks Is Free, but It's Important to Start Young 3
... Holder provides precise control of the thigh duri..., and maximum exposure of the proximal thigh durin...r can be used on both right and left legs and may ...file Leg Holder can be used with an Arthrex tourni...
...extremity for prepping before hip or knee surgery....rticularly helpful for supporting the leg with the...lding the foot/ankle in an externally rotated posi...helps eliminate the need for manual support.,The...
...ixator is ideal for trauma, foot and ankle or defo... products ,True/Lok External Fixation compone...frame assembly and the complexity of intra-operati... modular, preassembled distractors and hinges elim...
Adjustable Leg Support Stand
Medicine Products: